The country has approved Sinovac Biotech’s Covid-19 vaccine for use in the elderly, a letter from the food and drug agency shows, potentially changing the country’s strategy which has prioritised its working population first.
That strategy was partially due to limited data on the vaccine’s safety for the elderly, authorities have said.